Skip to main content
SpringerLink
Log in

No renal protection from volatile-anesthetic preconditioning in open heart surgery

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Purpose

Acute kidney injury (AKI) is a common complication of open heart surgery (OHS). Preconditioning with volatile anesthetics is well proven to provide myocardial protection. Renal protection provided by volatile-anesthetic preconditioning has also been investigated; however, it is still controversial at the clinical level. This study aimed to investigate whether preconditioning with volatile anesthetics could mediate renal protection in OHS.

Methods

A retrospective analytic study was designed. Medical records of patients (age ≥20 years) who had undergone OHS were reviewed. Types of anesthesia were classified as ‘opioid-based anesthesia’ (O group) and ‘volatile-anesthetic-based anesthesia’ (V group) according to the definitions given in the main text. Some medical records that had incomplete or ambiguous data were excluded. Renal protection was considered to be present if there was no clinical renal dysfunction as defined by the criteria given in the main text. AKI was considered to be present when there was a decrease of the postoperative estimated glomerular filtration rate (eGFR) that was >25 % of the preoperative eGFR. Also, postoperative 24-h oliguria (post-oliguria) and the provision of postoperative 48-h dialysis (post-dialysis) were considered. Differences between the O and V groups were tested by the appropriate statistics. A p value of <0.05 indicated significance.

Results

A total of 1,122 patients (702 males) were included in this study. The O and V groups included 704 and 418 patients, respectively. AKI was present in 9.52 and 8.37 % of the patients in the O and V groups, respectively (p = 0.532). Post-oliguria was found in 36.08 and 37.79 % of the patients in the O and V groups; and post-dialysis was provided in 3.98 and 4.31 %, respectively, of these patients; these two parameters showed no significant differences between the groups.

Conclusions

This study could not demonstrate volatile-anesthetic-mediated renal protection in OHS. Therefore, in practice, pharmacological preconditioning with volatile anesthetics did not seem to be beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Koyner JL, Bennette MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O’Conor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059–69.

    Article  PubMed  CAS  Google Scholar 

  2. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19–32.

    Article  PubMed  Google Scholar 

  3. Per-Olof J. Renal protection strategies in the perioperative period: best practice research. Clin Anesthesiol. 2004;18:645–60.

    Google Scholar 

  4. Tyagi P, Tayal G. Ischemic preconditioning of myocardium. Acta Pharmacol Sin. 2002;23:865–70.

    PubMed  CAS  Google Scholar 

  5. Riksen NP, Smits P, Rongen GA. Ischaemic preconditioning: from molecular characterisation to clinical application-part II. Neth J Med. 2004;62:409–23.

    PubMed  CAS  Google Scholar 

  6. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia–reperfusion injury: an update for anesthesiologists. Can J Anaesth. 2002;49:777–91.

    Article  PubMed  Google Scholar 

  7. Hawaleshka A, Jacobsohn E. Ischemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth. 1998;45:670–82.

    Article  PubMed  CAS  Google Scholar 

  8. Hu ZY, Liu J. Mechanism of cardiac preconditioning with volatile anesthetics. Anesth Intensive Care. 2009;47:532–8.

    Google Scholar 

  9. Minquet G, Joris J, Lamy M. Preconditioning and protection against ischaemia–reperfusion in non-cardiac organs: a place for volatile anesthetics? Eur J Anaesthesiol. 2007;24:733–45.

    Article  Google Scholar 

  10. Reiss ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol. 2004;286:H1603–7.

    Article  Google Scholar 

  11. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ. Volatile-anesthetic-induced cardiac preconditioning. J Anesth. 2007;21:212–9.

    Article  PubMed  Google Scholar 

  12. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Cardioprotection with volatile anesthetics in cardiac surgery. Asian Cardiovasc Thorac Ann. 2008;16:256–64.

    PubMed  Google Scholar 

  13. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am J Physiol Renal Physiol. 2000;278:F380–7.

    PubMed  CAS  Google Scholar 

  14. Lee HT, Emala CW. Protein kinase C and Gi/o proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol. 2001;12:233–40.

    PubMed  CAS  Google Scholar 

  15. Rahgozar M, Willgross DA, Gobe’ GC, Endre ZH. ATP-dependent K+ channels in renal ischemia reperfusion injury. Ren Fail. 2003;25:885–96.

    Article  PubMed  CAS  Google Scholar 

  16. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biomarkers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315–27.

    Article  PubMed  CAS  Google Scholar 

  17. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J Cardiothorac Vasc Anesth. 2006;20:684–90.

    Article  PubMed  CAS  Google Scholar 

  18. De Hert SG. Volatile anesthetics and cardiac function. Semin Cardiothorac Vasc Anesth. 2006;10:33–42.

    Article  PubMed  Google Scholar 

  19. Kohn P. Renal insufficiency after cardiac surgery: a challenging clinical problem. Eur Heart J. 2009;30:1824–7.

    Article  Google Scholar 

  20. Habbibey R, Pazoki-Toroudi H. Morphine dependence protects rat kidney against ischaemia–reperfusion injury. Clin Exp Pharmacol Physiol. 2008;35:1209–14.

    Article  Google Scholar 

  21. Toosy N, McMorris ELJ, Grace PA, Mathie RT. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 1999;84:489–94.

    Article  PubMed  CAS  Google Scholar 

  22. Rigalleau V, Lasseur C, Raffaitin C, Perlemoine C, Barthe N, Chauveau P, Combe C, Gin H. The Mayo clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects. Nephrol Dial Transplant. 2007;22:813–8.

    Article  PubMed  Google Scholar 

  23. Bakoush O, Grubb A, Rippe B. Inaccuracy of GFR predictions by plasma cystatin C in patients without kidney dysfunction and in advanced kidney disease. Clin Nephrol. 2008;69:331–8.

    PubMed  CAS  Google Scholar 

  24. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. Biomarkers of acute renal injury and renal failure. Shock. 2006;26:245–53.

    Article  PubMed  CAS  Google Scholar 

  25. Kumar AB. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011;114:964–70.

    Article  PubMed  Google Scholar 

  26. Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Med. 2011;9:11.

    Article  PubMed  Google Scholar 

  27. Lee HT, Emala CW. Adenosine attenuates oxidant injury in human kidney proximal tubular cells via A1 and A2a adenosine receptors. Am J Physiol Renal Physiol. 2002;282:F844–52.

    PubMed  CAS  Google Scholar 

  28. Lee HT, Emala CW. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury. J Am Soc Nephrol. 2002;13:2753–61.

    Article  PubMed  CAS  Google Scholar 

  29. Kim M, Kim M, Kim N, D’Agati VD, Emala CW, Lee HT. Isoflurane mediates protection from renal ischemia–reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol. 2007;293:F1827–35.

    Article  PubMed  CAS  Google Scholar 

  30. Lee HT, Chen sean WC, Doetschman TC, Deng C, D’ Agati VD, Kim M. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-β1 pathway. Am J Physiol Renal Physiol. 2008;295:F128–36.

    Article  PubMed  CAS  Google Scholar 

  31. Hashiquchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinase, JNK and ERK. Anesth Analg. 2005;101:1584–9.

    Article  Google Scholar 

  32. Adam F, Kauskot A, Rosa JP, Bryckaert M. Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost. 2008;6:2007–16.

    Article  PubMed  CAS  Google Scholar 

  33. Loveridge R, Schroeder F. Anaesthetic preconditioning. Contin Educ Anaesth Crit Care Pain. 2010;10:38–42.

    Article  Google Scholar 

  34. Tesch GH. Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective. Nephrology. 2010;15:609–16.

    Article  PubMed  CAS  Google Scholar 

  35. Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management and outcomes. BMJ. 2010;341:85–90.

    Article  Google Scholar 

  36. Kher A, Meldrum KK, Wang M, Tsai BM, Pitcher JM, Meldrum DR. Cellular and molecular mechanism of sex differences in renal ischemia–reperfusion injury. Cardiovasc Res. 2005;67:594–603.

    Article  PubMed  CAS  Google Scholar 

  37. Neugarten J, Acharya A, Silbiger SR. Effects of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319–29.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was accomplished with financial support from the Faculty of Medicine, Chulalongkorn University (Ratchadapisek Sompot fund No. 42/53). We would also like to offer special thanks to the in-training residents of the Department of Anesthesiology who assisted in data collection.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand

    Wacharin Sindhvananda, Krit Phisaiphun & Prut Prapongsena

Authors
  1. Wacharin Sindhvananda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krit Phisaiphun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prut Prapongsena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wacharin Sindhvananda.

About this article

Cite this article

Sindhvananda, W., Phisaiphun, K. & Prapongsena, P. No renal protection from volatile-anesthetic preconditioning in open heart surgery. J Anesth 27, 48–55 (2013). https://doi.org/10.1007/s00540-012-1461-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-012-1461-z

Keywords

Search

Navigation